Novo Nordisk Bucking The Trend By Investing In UK Science

By Natasha Allen – Hopefully this pioneering company will pave the way for further investment in the UK and start to allay post-Brexit fears!

LONDON, Jan 30 (Reuters) – Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain, undeterred by Brexit.

The Danish company said on Monday it would invest the money over 10 years in the centre based at the University of Oxford, which will employ 100 scientists hunting for new ways to treat type 2 diabetes.